Outcomes in severe sepsis and patients with septic shock: Pathogen species and infection sites are not associated with mortality

Critical Care Medicine

Volumn 39, Issue 8, 2011, Pages 1886-1895

  Zahar, Jean Ralph ^a   Timsit, Jean Francois ^b,e   Garrouste Orgeas, Maïté ^c   Français, Adrien ^c   Vesim, Aurélien ^l   Descorps Declere, Adrien ^d   Dubois, Yohann ^e   Souweine, Bertrand ^f   Haouache, Hakim ^g   Goldgran Toledano, Dany ^h   Allaouchiche, Bernard ⁱ   Azoulay, Elie ^j   Adrie, Christophe ^k  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

^b INSERM   (France)

^c SAINT JOSEPH HOSPITAL   (France)

^d HÔPITAL ANTOINE BÉCLÈRE   (France)

^e UNIV GRENOBLE ALPES   (France)

^f UNIVERSITY HOSPITAL OF CLERMONT FERRAND   (France)

^g HÔPITAL JEAN VERDIER   (France)

^h Gonesse General Hospital   (France)

ⁱ EDOUARD HERRIOT HOSPITAL   (France)

^j SAINT LOUIS HOSPITAL   (France)

^k université Paris Cité   (France)

^l NONE

more..

Author keywords

Outcome; pathogens; place of acquisition; severe sepsis; site of infection

Indexed keywords

ANTIINFECTIVE AGENT; CORTICOSTEROID; HYPERTENSIVE FACTOR;

ABDOMINAL INFECTION; ACINETOBACTER; ACUTE KIDNEY FAILURE; ACUTE RESPIRATORY FAILURE; ADULT; AGED; ARTERY CATHETER; ARTICLE; ARTIFICIAL VENTILATION; BACTEREMIA; CHRONIC KIDNEY FAILURE; CHRONIC LIVER FAILURE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CHRONIC RESPIRATORY FAILURE; COHORT ANALYSIS; COMA; COMMUNITY; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE EXACERBATION; DISEASE SEVERITY; ESCHERICHIA COLI; FEMALE; FUNGUS; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HEART FAILURE; HOSPITAL ADMISSION; HOSPITAL INFECTION; HOSPITALIZATION; HUMAN; IMMUNE DEFICIENCY; INTENSIVE CARE UNIT; INTRAVASCULAR CATHETER; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIDRUG RESISTANCE; MULTIPLE ORGAN FAILURE; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PATHOGENESIS; PATIENT MONITORING; PNEUMONIA; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSEUDOMONAS; SEPSIS; SEPTIC SHOCK; SHOCK; STENOTROPHOMONAS MALTOPHILIA; STREPTOCOCCUS PNEUMONIAE; SURVIVAL; SWAN GANZ CATHETER; URINARY TRACT INFECTION;

EID: 79961025625     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e31821b827c     Document Type: Article

References (41)

1. Adrie C, Alberti C, Chaix-Couturier C, et al: Epidemiology and economic evaluation of severe sepsis in France: Age, severity, infection site, and place of acquisition (community, hospital, or intensive care unit) as determinants of workload and cost. J Crit Care 2005; 20:46-58 (Pubitemid 40602223)
2. Moreno RP, Metnitz B, Adler L, et al: Sepsis mortality prediction based on predisposition, infection and response. Intensive Care Med 2008; 34:496-504 (Pubitemid 351623030)
3. Rubulotta F, Marshall JC, Ramsay G, et al: Predisposition, insult/infection, response, and organ dysfunction: A new model for staging severe sepsis. Crit Care Med 2009; 37: 1329-1335
4. Harbarth S, Garbino J, Pugin J, et al: Inappropriate initial antimicrobial therapy and its effect on survival in a clinical trial of immunomodulating therapy for severe sepsis. Am J Med 2003; 115:529-535 (Pubitemid 37352798)
5. Ferrer R, Artigas A, Suarez D, et al: Effectiveness of treatments for severe sepsis: A prospective, multicenter, observational study. Am J Respir Crit Care Med 2009; 180:861-866
6. Kumar A, Ellis P, Arabi Y, et al: Initiation of inappropriate antimicrobial therapy results in a fivefold reduction of survival in human septic shock. Chest 2009; 136:1237-1248
7. Cohen J, Cristofaro P, Carlet J, et al: New method of classifying infections in critically ill patients. Crit Care Med 2004; 32:1510-1526 (Pubitemid 38925180)
8. Combes A, Luyt CE, Fagon JY, et al: Early predictors for infection recurrence and death in patients with ventilator-associated pneumonia. Crit Care Med 2007; 35:146-154 (Pubitemid 46035690)
9. Misset B, Nakache D, Vesin A, et al: Reliability of diagnostic coding in intensive care patients. Crit Care 2008; 12:R95
10. Azoulay E, Pochard F, Garrouste-Orgeas M, et al: Decisions to forgo life-sustaining therapy in ICU patients independently predict hospital death. Intensive Care Med 2003; 29:1895-1901 (Pubitemid 37487121)
11. Calandra T, Cohen J: The international sepsis forum consensus conference on definitions of infection in the intensive care unit. Crit Care Med 2005; 33:1538-1548 (Pubitemid 40980610)
12. Pham LH, Brun-Buisson C, Legrand P, et al: Diagnosis of nosocomial pneumonia in mechanically ventilated patients. Comparison of a plugged telescoping catheter with the protected specimen brush. Am Rev Respir Dis 1991; 143:1055-1061
13. Mandell LA, Wunderink RG, Anzueto A, et al: Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of communityacquired pneumonia in adults. Clin Infect Dis 2007; 44(Suppl 2):S27-S72 (Pubitemid 46290553)
14. Solomkin JS, Mazuski JE, Bradley JS, et al: Diagnosis and management of complicated intra-abdominal infection in adults and children: Guidelines by the Surgical Infection Society and the Infectious Diseases Society of America. Clin Infect Dis 50:133-164
15. Hospital-acquired pneumonia in adults: Diagnosis, assessment of severity, initial antimicrobial therapy, and preventive strategies. A consensus statement, American Thoracic Society, November 1995. Am J Respir Crit Care Med 1996; 153:1711-1725
16. Sobel JD, Kaye D: Urinary tract Infection. Sixth Edition. In: Principle and Practice of Infectious Diseases. Philadelphia, Elsevier, 2005, pp 875-905
17. Fine JP, Gray RJ: A proportional hazards model for the model for the subdistribution of a competing risk. JASA 1999; 94:496-509
18. Levi M, van der Poll T: Coagulation in sepsis: All bugs bite equally. Crit Care 2004; 8:99-100 (Pubitemid 38436414)
19. Opal SM, Garber GE, LaRosa SP, et al: Systemic host responses in severe sepsis analyzed by causative microorganism and treatment effects of drotrecogin alfa (activated). Clin Infect Dis 2003; 37:50-58 (Pubitemid 36836644)
20. Esper AM, Moss M, Lewis CA, et al: The role of infection and comorbidity: Factors that influence disparities in sepsis. Crit Care Med 2006; 34:2576-2582 (Pubitemid 44413055)
21. Vincent JL, Rello J, Marshall J, et al: International study of the prevalence and outcomes of infection in intensive care units. JAMA 2009; 302:2323-2329
22. Alberti C, Brun-Buisson C, et al: Epidemiology of sepsis and infection in ICU patients from an international multicenter cohort study. Intensive Care Med 2002; 28:108-121 (Pubitemid 34293822)
23. Brun-Buisson C: The epidemiology of the systemic inflammatory response. Intensive Care Med 2000; 26(Suppl 1):S64-S74 (Pubitemid 30184495)
24. Timsit JF: Sepsis: Let's go back to the infectious process. Crit Care Med 2004; 32:1616-1617
25. Angus DC, Linde-Zwirble WT, Lidicker J, et al: Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001; 29:1303-1310 (Pubitemid 32641789)
26. Opal SM, Martin GS, Mannino DM, Eaton S, et al: The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 2003; 348:1546-1554 (Pubitemid 36437931)
27. Calandra T: Antibiotic usage and resistance: Gaining or losing ground on infections in critically ill patients? JAMA 2009; 302:2367-2368
28. Kinasewitz GT, Yan SB, Basson B, et al: Universal changes in biomarkers of coagulation and inflammation occur in patients with severe sepsis, regardless of causative microorganism. Crit Care 2004; 8:R82-R90
29. Wheeler AP: Recent developments in the diagnosis and management of severe sepsis. Chest 2007; 132:1967-1976
30. Kumar A, Roberts D, Wood KE, et al: Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 2006; 34:1589-1596 (Pubitemid 43810035)
31. Rangel-Frausto MS, Pittet D, Costigan M, et al: The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study. JAMA 1995; 273: 117-123
32. Brun-Buisson C, Meshaka P, Pinton P, et al: EPISEPSIS: A reappraisal of the epidemiology and outcome of severe sepsis in French intensive care units. Intensive Care Med 2004; 30:580-588 (Pubitemid 38530092)
33. Garrouste-Orgeas M, Timsit JF, et al: Excess risk of death from intensive care unitacquired nosocomial bloodstream infections: A reappraisal. Clin Infect Dis 2006; 42: 1118-1126
34. Ibrahim EH, Sherman G, Ward S, et al: The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest 2000; 118:146-155 (Pubitemid 30485502)
35. Zahar JR, Clec'h C, Tafflet M, et al: Is methicillin resistance associated with a worse prognosis in Staphylococcus aureus ventilator-associated pneumonia? Clin Infect Dis 2005; 41:1224-1231 (Pubitemid 41532663)
36. Reyes WJ, Brimioulle S, Vincent JL: Septic shock without documented infection: An uncommon entity with a high mortality. Intensive Care Med 1999; 25:1267-1270
37. Roghmann MC: Predicting methicillin resistance and the effect of inadequate empiric therapy on survival in patients with Staphylococcus aureus bacteremia. Arch Intern Med 2000; 160:1001-1004
38. Kim SH, Park WB, Lee CS, et al: Outcome of inappropriate empirical antibiotic therapy in patients with Staphylococcus aureus bacteraemia: Analytical strategy using propensity scores. Clin Microbiol Infect 2006; 12:13-21
39. Falagas ME, Siempos II, Bliziotis IA, et al: Impact of initial discordant treatment with betalactam antibiotics on clinical outcomes in adults with pneumococcal pneumonia: A systematic review. Mayo Clin Proc 2006; 81: 1567-1574 (Pubitemid 44871900)
40. Osih RB, McGregor JC, Rich SE, et al: Impact of empiric antibiotic therapy on outcomes in patients with Pseudomonas aeruginosa bacteremia. Antimicrob Agents Chemother 2007; 51:839-844 (Pubitemid 46355264)
41. Zaragoza R, Artero A, Camarena JJ, et al: The influence of inadequate empirical antimicrobial treatment on patients with bloodstream infections in an intensive care unit. Clin Microbiol Infect 2003; 9:412-418 (Pubitemid 36758130)